Medical Devices: Evidence and Research
Open access peer-reviewed scientific and medical journals.
Dove Medical Press is now a member of the Open Access Initiative
An Author's Guide
A guide to help authors get their paper published.
Support Open Access and Dove Press
Promotional Article Monitoring - further details
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Validation of the BPLab® 24-hour blood pressure monitoring system according to the European standard BS EN 1060-4:2004 and British Hypertension Society protocol
(5015) Total Article Views
Authors: Koudryavtcev SA, Lazarev VM
Published Date October 2011
Volume 2011:4 Pages 193 - 196
Sergey A Koudryavtcev, Vyacheslav M Lazarev
Department of Military Medicine, Municipal Medical and Preventive Treatment Facility, ‘Clinical Hospital No 12’, Sormovsky District, Nizhny Novgorod, Russian Federation
Introduction: Automatic blood pressure (BP) measuring devices are more and more often used in BP self-checks and in 24-hour BP monitoring. Nowadays, 24-hour BP monitoring is a necessary procedure in arterial hypertension treatment. The aim of this study was to validate the BPLab® ambulatory blood pressure monitor according to the European standard BS EN 1060-4:2004 and the British Hypertension Society (BHS) protocol, as well as to work out solutions regarding the suitability of using this device in clinical practice.
Methods: A group of 85 patients of both sexes and different ages, who voluntarily agreed to take part in the tests and were given detailed instructions on the measurement technique were recruited for this study. The results of the BP measurement obtained by a qualified operator using the BPLab® device were compared with the BP values measured using the Korotkov auscultatory method. Data were obtained simultaneously by two experts with experience of over 10 years and had completed a noninvasive BP measurement standardization training course. Discrepancies in the systolic and diastolic BP measurements (N = 510; 255 for each expert) were analyzed according to the criteria specified in the BHS-93 protocol.
Results: The device passed the requirements of the European Standard BS EN 1060-4:2004 and was graded ‘A’ according to the criteria of the BHS protocol for both systolic BP and diastolic BP.
Conclusion: The BPLab® 24-hour ambulatory blood pressure monitoring device may be recommended for extensive clinical use.
Keywords: 24-hour blood pressure monitoring, device, validation, BPLab®
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter
Readers of this article also read:
"I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University.
- MLA'14 -
May 16–21, 2014
- Formulation and evaluation of drug-loaded targeted magnetic microspheres for cancer therapy
- Intracellular heavy metal nanoparticle storage: progressive accumulation within lymph nodes with transformation from chronic inflammation to malignancy
- Applications of gold nanoparticles in cancer nanotechnology
- Fungus-mediated biological synthesis of gold nanoparticles: potential in detection of liver cancer